CTNNB1 clinical trials at UCSF

1 research study open to eligible people

CTNNB1 is a gene that directs the growth of cells. UCSF is investigating how well FOG-001 works for individuals with advanced or metastatic tumors. The trials are focused on understanding safety and how patients respond to the treatment.

FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations

Last updated: October 22, 2025